InvestorsHub Logo
Followers 22
Posts 1558
Boards Moderated 0
Alias Born 01/23/2014

Re: ruezim post# 1844

Sunday, 09/01/2019 3:47:40 AM

Sunday, September 01, 2019 3:47:40 AM

Post# of 2676
Society for the Study of Behavioral Phenotypes Symposium, Birmingham, UK (3 days). Zynerba Pharmaceuticals (NASDAQ:ZYNE): Cannabidiol for the management of autism, Fragile X syndrome and 22q11.2 Deletion syndrome.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ZYNE News